{
  "id": 633379,
  "title": "Zydus Lifesciences shares drop 3% after Q1 earnings. Here's why Nuvama upgraded rating, hiked target",
  "url": "https://urgent.news/2026/08/12/zydus-lifesciences-shares-drop-3-after-q1-earnings-heres-why-nuvama",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-12T04:18:26.000Z",
  "source": {
    "name": "The Economic Times - Top News",
    "slug": "the-economic-times-top-news",
    "url": "https://economictimes.indiatimes.com/markets/stocks/news/zydus-lifesciences-shares-drop-3-after-q1-earnings-heres-why-nuvama-upgraded-rating-hiked-target/articleshow/133169721.cms"
  },
  "original_language": "en",
  "account": null,
  "summary": "Shares of Zydus Lifesciences saw a decline of more than two percent following the announcement of a notable profit drop. The net profit plunged thirty-six percent year-on-year for the first quarter, despite a nearly twenty-two percent increase in operational revenue. Expenses surged by over forty-one percent. However, the managing director remains optimistic about future prospects. Analysts at…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}